These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24477242)

  • 21. Growth promoting peptides in diabetic and non-diabetic pregnancy: interactions with trophoblastic receptors and serum carrier proteins.
    Culler FL; Tung RF; Jansons RA; Mosier HD
    J Pediatr Endocrinol Metab; 1996; 9(1):21-9. PubMed ID: 8887130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term hypocaloric nutrition but not bed rest decrease insulin sensitivity and IGF-I bioavailability in healthy subjects: the importance of glucagon.
    Nygren J; Thorell A; Brismar K; Karpe F; Ljungqvist O
    Nutrition; 1997; 13(11-12):945-51. PubMed ID: 9433709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis.
    Chen JW; Nielsen MF; Caumo A; Vilstrup H; Christiansen JS; Frystyk J
    Eur J Endocrinol; 2006 Aug; 155(2):285-92. PubMed ID: 16868142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
    Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
    Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) in diabetic pregnancy: relationship to macrosomia.
    Yan-Jun L; Tsushima T; Minei S; Sanaka M; Nagashima T; Yanagisawa K; Omori Y
    Endocr J; 1996 Apr; 43(2):221-31. PubMed ID: 9026269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
    Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the insulin-like growth factor system by insulin in burn patients.
    Lang CH; Fan J; Frost RA; Gelato MC; Sakurai Y; Herndon DN; Wolfe RR
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2474-80. PubMed ID: 8675563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
    Skjaerbaek C; Frystyk J; Møller J; Christiansen JS; Orskov H
    Eur J Endocrinol; 1996 Dec; 135(6):672-7. PubMed ID: 9025711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous s.c. infusion rather than twice-daily injections of IGF-I more effectively increases serum IGF binding protein-3 in female monkeys.
    Wilson ME; Lackey SL
    Eur J Endocrinol; 1999 Sep; 141(3):303-12. PubMed ID: 10474130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs.
    Vinter-Jensen L; Juhl CO; Frystyk J; Dajani EZ; Oksbjerg N; Flyvbjerg A
    J Endocrinol; 1996 Dec; 151(3):401-7. PubMed ID: 8994385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.